Pfizer Inc reports results for the quarter ended June 30 - Earnings Summary

Pfizer

04/08/2026 14:31

Pfizer Inc PFE.N reported quarterly adjusted earnings of 77 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 78 cents.  The mean expectation of twenty analysts for the quarter was for earnings of 68 cents per share. Wall Street expected results to range from 61 cents to 76 cents per share.
Revenue rose 2.6% to $15.03 billion from a year ago; analysts expected $14.41 billion. 
Pfizer Inc's reported EPS for the quarter was a loss of 4 cents​.
The company reported a quarterly loss of $248 million.
Pfizer Inc shares had risen by 3.9% this quarter and gained 0.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 11 "strong buy" or "buy," 19 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is  "buy."
Wall Street's median 12-month price target for Pfizer Inc is $28.00, about 10.6% above its last closing price of $25.03
This summary was machine generated from LSEG data August 4 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.68
0.77
Beat
Mar. 31 2026 
0.72
0.75
Beat
Dec. 31 2025 
0.57
0.66
Beat
Sep. 30 2025 
0.63
0.87
Beat